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Abstract.  Expression of the leukocyte (f12) integrins is 
required for many functions of activated neutrophils 
(PMN), even when there is no recognized ligand for 
any/52 integrin. To investigate the hypothesis that/52 
integrins may be involved in a signal transduction 
pathway related to cytoskeletal reorganization, we ex- 
amined whether/52 integrins have a role in tyrosine 
phosphorylation of the cytoskeletal protein paxillin. 
Treatment of PMN in suspension with phorbol esters, 
f-Met-Leu-Phe, and TNF-ct resulted in paxillin tyro- 
sine phosphorylation. However, treatment of/5z- 
deficient (LAD) PMN failed to induce paxillin tyro- 
sine phosphorylation. Normal PMN phosphorylated 
paxillin in response to adhesion to immune com- 
plexes, while the LAD PMN did not. Adhesion of 
phorbol ester activated-LAD PMN to the extracellular 
matrix proteins fibronectin, laminin, and vitronectin 
failed to induce paxillin tyrosine phosphorylation. 
Treatment of activated normal PMN with mAb 
directed against the/52  integrin a  chains demonstrated 
that CR3 (o~Mfl2) was required for paxillin phosphory- 
lation. Transfection of the cell line K562 with CR3 
confirmed that CR3 ligation resulted in paxillin tyro- 
sine phosphorylation. As a control, K562 transfected 
with CR2 (CD21)  which bound equally avidly to the 
same complement C3-derived ligand (C3bi) as the 
CR3 transfectants, showed no enhanced tyrosine phos- 
phorylation of paxillin upon receptor ligation. While 
both CR2 and CR3 transfectants showed efficient ad- 
hesion to a C3bi-coated surface, only the CR3 trans- 
fectants spread during adhesion and phosphorylated 
paxillin.  Together these data demonstrate that CR3 is 
required for paxillin phosphorylation during activation 
of both adherent and nonadherent PMN.  Even PMN 
activated in suspension or by adhesion to immune 
complexes, when no CR3 ligand is apparent, still  re- 
quire CR3 for a signal transduction pathway leading to 
paxillin tyrosine phosphorylation. This pathway is 
likely to be important for PMN function in inflamma- 
tion and host defense. 
C 
IRCULATING PMN are quiescent cells which became 
activated  in response  to a variety of soluble  stim- 
uli including cytokines, formyl-methionine-leucine- 
phenylalanine (fMLP), t and phorbol esters.  After activa- 
tion  polymorphonuclear  neutrophils  (PMN)  migrate  to 
inflammatory sites, spread on extracellular matrix, activate 
the  NADPH  oxidase  and  arachidonate metabolism,  and 
markedly increase the efficiency of ingestion of opsonized 
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particles. Many of these functions of activated PMN are de- 
pendent on the presence of complement receptor 3 (CR3), a 
member of the t2 (CD18) integrin family, even when there 
is no known CR3 ligand present (20). However, the mecha- 
nism of involvement of CR3 in these diverse functions is in- 
completely understood.  A  common component of many 
CR3-dependent functions is the requirement for reorganiza- 
tion of the cytoskeleton. Thus, a testable hypothesis is that 
one essential role for CR3 in PMN activation is in a signal 
transduction  pathway  for  cytoskeletal  reorganization.  A 
potential  target for such a signal transduction event is the 
microfilament-associated protein paxiUin (15, 26). Paxillin is 
a vinculin-binding  protein which becomes tyrosine phos- 
phorylated in fibroblasts after integrin ligation and which is 
present in focal contacts (7, 27). In addition, tyrosine phos- 
phorylation  of  paxiUin  increases  during  IgG-mediated 
phagocytosis by macrophages and after bombesin activation 
of 3T3 cells (18, 34). Paxillin also binds to the SH3 domain 
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a role in localizing signal transduction molecules to sites of 
organized cytoskeleton (30). We therefore hypothesized that 
paxillin  phosphorylation  may be associated with  82  inte- 
grin-dependent  signal transduction  in PMN. In this work, 
we have investigated  whether tyrosine phOsphorylation  of 
paxillin increases during PMN activation, and we have tested 
the hypothesis that 82 integrins  are required for this event. 
Our results demonstrate that tyrosine phosphorylation of 
paxillin is induced by a variety of soluble and adhesive stim- 
uli in PMN. In all cases, this phosphorylation is absent in 
PMN genetically deficient in B2 integrins.  Monoclonal anti- 
bodies against the various/~2-associated  ct chains  demon- 
strate that CR3, the most abundant/32 integrin on PMN, is 
the  essential  integrin  required  for paxillin  tyrosine phos- 
phorylation.  K562 cells transfected with CR3 confirm that 
CR3 ligation causes paxillin tyrosine phosphorylation. These 
data show that CR3 is required for paxillin phosphorylation 
in response to a broad range of adherent and soluble PMN 
activators  and  suggest that  paxillin  may be an  important 
mediator of the many diverse functions of activated PMN for 
which CR3 is required. 
Materials and Methods 
Cells 
PMN were purified from heparinized blood of healthy adult donors as de- 
scribed (19). PMN were pretreated with 5 mM disopropyl fluorophosphate 
for 10 min at room temperature.  Leukocyte adhesion deficiency (LAD) 
PMN were obtained from a patient followed at Baylor College of Medicine 
who has a complete absence of/~2 integrin expression (20). The LAD pa- 
tient is a 15-yr-old female who showed no clinical evidence of infection at 
the times PMN were studied. K562 were grown in RPMI with 10% FCS 
in a 5% CO2 environment. 
cDNA Clones and Cell Transfection 
The/32 eDNA was isolated from a DMSO-differentiated HL60 eDNA li- 
brary, which was the gift of Drs. Brian Volpp and William Nauseef (29), 
and cloned into pSFFV-neo (13). The aM eDNA was the gift of Dr. Timo- 
thy Springer, Harvard Medical School (Boston, MA) (11). For transfection, 
the aM eDNA was cloned into the stable expression vector pRc/RSV (In- 
vitrogen,  San Diego, CA). K562 were cotransfected with the aM and ~2 
cDNAs by electroporation at 225 V and 500 #F using a gene pulser (Biorad 
Labs., Richmond, CA). Transfected cells were selected in 600 #g/ml G418 
(Geneticin, GIBCO BRL, Gaithersburg, MD) and a population with high 
level CR3 expression was derived using FACS. Control K562 were trans- 
fected with vector alone (pRc/RSV or pSFFV-neo) by an identical protocol. 
K562 were transfected with the CR2 eDNA in the pSFFV-neo vector as de- 
scribed (8). 
Monoclonal Antibodies and Reagents 
ElM (anti-CD18, IgG2a), 944  (anti-CDllb,  IgG2a), and 3.9 (anti-CDllc, 
IgGl) were the generous gifts of Dr. Sum Wright, Rockefeller University 
(New York, NY); Dr. Robert Todd, University of Michigan (Ann Arbor, 
MI); and Dr. Nancy Hogg, Imperial Cancer Research Fund (London, UK), 
respectively, (24,  25, 33).  10B5 (anti-CDllb,  IgG1) was prepared as de- 
scribed (16). TSI-22 (anti-CDlla,  IgG1) (10), W632 (anti-HLA I, IgG2a), 
and  HB5  (anti-CR2)  were  from the American  Type Culture  Collection 
(Rockville, MD). Paxillin mAb was from Transductiun Laboratories (Lex- 
ington,  KY), and anti-phosphotyrosine mAb 4G10 was from UBI (Lake 
Placid,  NY).  PDBu and fMLP were from Sigma Chem.  Co. (St. Louis, 
MO). Recombinant tumor necrosis factor-or (TNF-ct was from UBI (Lake 
Placid, NY). 
Opsonized Particles 
3-#M latex beads (Folysciences Inc., Warrington, PA) were opsunized by 
rotating with 20/~g/rnl human IgM (Calbiocbem, San Diego, CA) in 0.1 M 
carbonate buffer pH 9 for 1 h at 37°C. Beads were then washed three times 
with GVBS (veronai buffered saline with 0.1% gelatin, 0.15 mM Ca  2+, and 
1 mM Mg  2+) and incubated with a 1:3 dilution of serum in this buffer for 
1 h at 37°C. IgG- and C3bi-opsonized sheep red blood cells were prepared 
as described (16, 19). FOr assays of paxillin tyrosine phosphorylation 3  x 
105 cells were incubated rocking at 37°C with 3 x  10  a opsonized particles 
in I-IBSS  ++ (1.5 mM Ca  2+, 1.5 Mg  2+) with 1% HSA for the indicated times. 
Attachment indices (AI) were determined by counting the number of parti- 
cles attached per 100 PMN or K562 cells. 
CeU Adhesion 
Protein-coated surfaces were prepared by coating with poly-L-lysine as de- 
scribed (6),  followed by BSA and anti-BSA for immune complex-coated 
surfaces  (17), or  10  #g/ml  human  IgM  in  PBS  for  45  min  at  RT. 
Complement-coated surfaces were generated by incubating immune com- 
plex-coated  surfaces or IgM-coated surfaces with a 1:5 dilution of serum 
in GVBS for 1 h at 37°C. Cells were incubated in I-IBSS  ++ with 1% HSA 
at 37 ° for the indicated times. K562 adhesion, cell spreading, and paxillin 
phosphorylation were equivalent on either immune ccomplex/complement- 
coated surfaces or IgM/complement-coated  surfaces. 
Cells in Suspension 
3  ×  106 PMN were suspended in polypropylene Eppendoff  tubes in 1 ml 
HBSS  ++ with 1% human serum albumin and incubated rocking at 30 cy- 
cles per minute at 37°C in room air. Under these conditions there was no 
evidence of cell adhesion (number of cells in suspension equal before and 
after incubation with or without TNF) or aggregation (assessed microscopi- 
cally) after stimulation with TNF-c~. 
lmmunoprecipitations and lmmunoblotting 
3  x  106 PMN or K562 were lysed per point in ice cold Tris-buffered sa- 
line, with 0.1% sodium azide (150 mM NaCI, 50 mM Tris-Cl, pH 7.5) con- 
taining 1% Triton X-100, 1% deoxycholate, 1 mM EGTA, 1 mM EDTA, 
50 #g/ml leupeptin, 50 #g/ml aprotinin, 200 #M sodium orthovanadate, and 
1 mM H202 as described (3). For PMN, lysis buffer also contained 2 mM 
diisopropyl fluorophosphate. To determine paxillin phosphorylatiun after 
adhesion, adherent and nonadherent cells were combined by scraping ad- 
herent cells into lysis buffer and combining with the pellet of nonadherent 
cells obtained by centrifugation for 30 s at 2,000 g. Total cell lysates were 
rotated at 4°C for 30 min followed by centrifngation at 10,000 g for 10 rain. 
Samples were then then rotated for 1 h at 4°C with paxillin mAb, followed 
by the addition of goat anti-mouse IgG Sepharose (Organon Teknika, West 
Chester, PA) and rotated for an additional hour. 
Immunoprecipitates were washed three times in Tris-buffered saline with 
0.1% Triton X-100, 0.1% deoxycholate, 0.1 mM EDTA, 25 #g/rnl leupeptin, 
25  /zg/rnl aprotinin,  200  /.tM sodium orthovanadate, and  1 mM  H202. 
Whole cell lysates were prepared by lysing 105  cells directly  in sample 
buffer. Samples were heated  for 5 min at  100°C in sample buffer with 
/3-mercaptoethanol, separated on SDS-PAGE, and transferred electropho- 
reticaily to PVDF membrane (Millipore, Bedford, MA). Blots were stained 
with Coomassie blue, destained, and then blocked either overnight at 4°C 
or for 30 min at 37°C in blocking buffer (NaCI 150 mM, 10 mM Tris-Cl 
pH 8, 1% NP-40 and 2 % BSA). Membranes were then incubated for 75 rain 
at RT with primary antibody (anti-phosphotyrosine mAb 4G10 at 0.2 #g/ml 
in blocking buffer), followed by washing in the same buffer without BSA. 
Blots  were  incubated  with  secondary  antibody  (HRP-conjugated  anti- 
mouse IgG2b) (Caltag, San Francisco, CA) 1/~g/ml in blocking buffer for 
45 min at RT, washed, and then developed using an enhanced chemilumi- 
nescence kit (Amersham,  UK). To determine total paxillin loading, blots 
were stripped as described (3), and probed as above using 0.2 #g/ml paxiilin 
mAb followed by 1:1,000 dilution of  HRP-conjugated anti-mouse IgG (Cap- 
pel, Durham,  NC). 
Data Presentation 
Anti-pbosphotymsine Western blots shown in the figures are of representa- 
tive experiments. All experiments on normal PMN and K562 transfectants 
were performed 2-5 times with equivalent results. 
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paxillin  in PMN.  PMN  in suspension 
were incubated with buffer (C), TNF-a 
(50 U/ml), or PDBu (15 ng/ml) for 25 
rain at 37°C.  Paxillin  immunoprecipi- 
tares  were  run  on  SDS-PAGE  and 
immunoblotted with the anti-phospho- 
tyrosine mAb 4(310 (left panel).  PMN 
in suspension demonstrate tyrosine phos- 
phorylation of paxillin  after activation 
with TNF-c~ or phorbol esters.  Reprob- 
ing of the same blot with anti-paxillin 
mAb is shown in the right panel. In each 
case, the entire sample was immunopre- 
cipitated  with antipaxiUin;  and there is 
equivalent or greater paxillin  in control 
lanes compared with activated samples. 
The consistent decrease in paxillin  after 
phorbol ester or fMLP activation is prob- 
ably due to proteolysis.  Numbers to the 
right in each panel refer to Mr markers. 
Results 
Soluble PMN Activators Cause 
PaxiUin Phosphorylation  by a 1~2 
Integrin-dependent  Mechanism 
To determine  whether  paxillin  was  phosphorylated  in  re- 
sponse  to activating  stimuli  in  PMN,  we assayed paxillin 
phosphorylation in unactivated  PMN and in  PMN treated 
with  the  phorbol  ester  phorbol  dibutyrate  (PDBu),  the 
chemotactic  peptide  fMLE  and  the  cytokine  TNF-~.  All 
three stimuli activate PMN, as judged by increases in phago- 
cytosis, adhesiveness,  and oxygen metabolism (14, 20). All 
three  activators  caused  a  significant  increase  in  tyrosine 
phosphorylation of paxillin  (Figs.  1  and  2).  Treatment  of 
PMN from a patient with LAD, which lack all/32 integrins, 
with either PDBu, fMLP, or TNF-o~ failed to induce tyrosine 
Figure 2. Paxillin phosphorylation is compared for normal and/32- 
deficient (LAD) PMN. (,4) PMN in suspension were incubated with 
buffer, PDBu (15 ng/ml),  or fMLP (10-tM)  for 25 rain at 37°C. 
Paxillin  immunoprecipitates  were  run  on  SDS-PAGE  and  im- 
munoblotted with the anti-phosphotyrosine mAb 4(310. Enhanced 
tyrosine phosphorylation of paxillin  in response to activation  was 
seen in normal but not LAD PMN. Reprobing of  the same blot with 
anti-paxiUin mAb is shown on the fight and demonstrates equiva- 
lent or greater paxillin  loading from LAD PMN compared with 
controls.  Activation results in a shift of  paxillin to a higher molecu- 
lar weight.  This shift in size is independent  of tyrosine phosphory- 
lation and occurs equivalently in control and LAD PMN. (B) Con- 
trol and/~2-deficient (LAD) PMN in suspension  were incubated for 
10 or 25 rain with PDBu (15 ng/ml) or TNF-c~ (50 U/ml). Paxillin 
immunoprecipitates  were run on SDS-PAGE and phosphotyrosine 
immunoblotted.  Again tyrosine phosphorylation of paxillin  in re- 
sponse to activation was seen in normal but not LAD PMN. Paxil- 
lin phosphorylation increases markedly between 2 and 10 min after 
stimulation  and remains sustained as long as the PMN are viable. 
There is some variability in the magnitude of  tyrosine phosphoryla- 
tion in response to each stimulus  depending on the blood donor. 
On average, TNF gives less than half of the intensity  of the PDBu 
response when developed  with anti-PY. 
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that paxillin tyrosine phosphorylation occurs during PMN 
activation of  nonadherent cells. This phosphorylation of  pax- 
illin requires expression of/32 integrins. Immunoprecipita- 
tion of  the activated cells with antiphosphotyrosine, followed 
by antipaxillin; and detection with antipaxillin demonstrated 
that <6 % of  the total pool of  paxillin was detected as tyrosine 
phosphorylated by this method (data not shown). However, 
treatment of PMN with 100 #M vanadate and 2 mM H202, 
inhibitors of tyrosine phosphatases (21), markedly increased 
the proportion of tyrosine phosphorylated paxillin in the ac- 
tivated cells. These data suggest that the tyrosine phosphory- 
lation  of paxillin  is  tightly  regulated  by phosphatases  in 
PMN. 
Because PMN activation with PDBu and fMLP leads to 
132  integrin-dependent  homotypic  PMN  aggregation,  we 
considered the possibility that PMN aggregation initiates a 
132  integrin-dependent  signal  transduction  pathway.  How- 
ever, TNF-ot is reported not to induce PMN aggregation (2), 
and we observed no aggregation microscopically, yet TNF-c~ 
does stimulate paxillin phosphorylation (Fig.  1). Similarly, 
when PMN were diluted 50-fold before PDBu stimulation, 
no aggregation was observed, but paxillin phosphorylation 
was unaffected (data not shown). These data disassociate sta- 
ble PMN aggregation from/32 integrin-dependent paxillin 
phosphorylation. 
7)~osine Phosphorylation of  PaxiUin in 
Adherent PMN Requires [32 Integrins 
To test whether adhesion was a stimulus for paxillin phos- 
phorylation in PMN we used immune complex- or extracel- 
lular  matrix  protein-coated  surfaces.  Immune  complex- 
coated surfaces were tested initially since both normal and 
LAD PMN can adhere and spread on this surface (1, 17). Af- 
ter adhesion to immune complexes, normal PMN showed a 
marked  increase  in  paxiUin  tyrosin phosphorylation,  but 
LAD  PMN  did  not  (Fig.  3).  Thus,  in  PMN,  Fc gamma 
receptor-mediated activation of paxillin phosphorylation re- 
quires CD18.  However, not all tyrosine phosphorylation in- 
duced by FcR ligation requires expression of ~2 integrins. 
The increase in tyrosine phosphorylated proteins seen in a 
whole cell lysate after adhesion to immune complexes was 
almost indistinguishable  between LAD  and  normal  PMN 
(Fig.  3). 
In mouse macrophages,  interaction with IgG-opsonized 
particles has been shown to induce paxillin tyrosine phos- 
phorylation  (18).  However,  despite  avid binding  of IgG- 
opsonized particles  by  human  PMN,  neither control  nor 
LAD  PMN  demonstrated paxillin  phosphorylation in  re- 
sponse to this stimulus (Fig.  3). 
Adhesion to extracellular matrix-coated surfaces also was 
tested as a  stimulus for paxillin tyrosine phosphorylation. 
Since PMN adhere poorly to integrin ligands in the absence 
of activation (5), PMN were treated with PDBu before adhe- 
sion to fibronectin, laminin, and vitronectin. In no case did 
adhesion,  even after phorbol  stimulation lead  to  paxillin 
phosphorylation in  LAD  PMN  (Fig.  3).  Although  LAD 
PMN  demonstrate  a  /32  integrin-independent  binding  to 
laminin  through  a6/3~ (4),  this  is  not  sufficient to  induce 
paxillin phosphorylation. Thus, paxillin phosphorylation in 
PMN in response to both adherent and nonadherent stimuli 
is dependent on/32 integrins. 
Figure 3. PMN tyrosine phos- 
phorylation of paxiUin in re- 
sponse to IgG and adhesion. 
Control  and  /3:-deficient 
(LAD) PMN were adhered to 
immune complex-coated sur- 
faces for 10 min (lanes 1 and 
2) or 25 rain (lanes 3 and 4), 
followed by paxillin immuno- 
precipitation and phosphotyro- 
sine immunoblotting. Control 
PMN show a marked tyrosine 
phosphorylation  of  paxillin 
after adhesion to an immune 
complex-coated surface, while 
fl2-deficient  PMN (LAD) failed 
to  phosphorylate  paxillin. 
(Lanes 5 and 6) PMN were in- 
cubated for 25 rain in suspen- 
sion with IgG-opsonized  sheep 
red blood cells. Neither con- 
trol  nor  /$z-deficient PMN 
(LAD) phosphorylated paxil- 
lin in response to Fc'rR liga- 
tion in suspension. (Lanes  7 
and 10) PMN were incubated 
for 25 min in suspension (C) 
or adherent to immune com- 
plexes (ICs). The whole cell lysate was run on SDS-PAGE and phosphotyrosine immunoblotted. Adhesion to an immune complex-coated 
surface induced tyrosine phosphorylation of numerous proteins in both control and LAD PMN.  (Lanes 11-16) Control and LAD PMN 
were stimulated with PDBu and allowed to adhere to fibronectin-, laminin-, or vitronectin-coated surfaces for 25 min. Paxillin immuno- 
precipitates were immunoblotted with anti-phosphotyrosine rnAb. LAD PMN failed to phosphorylate paxillin in response to PDBu stimula- 
tion or adhesion to these extracellular matrix protein-coated  surfaces. Mr markers were as in Fig.  1. 
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Phosphorylation of  PaxUlin in PMN 
LAD PMN lack all/~2 integrins.  To determine whether any 
single one of the three/~2 integrins was necessary for paxil- 
lin phosphorylation in response to PMN activation, normal 
PMN were incubated with inhibitory antibodies to OtL, OtM, 
and Otx, and to the common/~2 chain before activation with 
PDBu.  mAb directed against otM and/52 resulted in almost 
complete inhibition of phorbol ester-induced paxillin tyro- 
sine phosphorylation (Fig. 4).  In contrast mAb against OtL 
and CXx had no effect on paxillin tyrosine phosphorylation. 
These data suggest that -u/~2 (CR3) is required for paxillin 
phosphorylation during PMN activation. 
Figure 4. Monoclonal antibody inhibition of  paxillin tyrosine phos- 
phorylation.  PMN in suspension were incubated  +  PDBu (15 ng/ 
ml) in the presence  of mAb against the different/32 integrins  or 
HLA class  I  as a control.  Paxillin was immunoprecipitated  and 
phosphotyrosine  detected  as in Fig.  I. mAb against the/32 chain 
0B4) and the CR3 cx chain (944) inhibited paxillin tyrosine phos- 
phorylation.  In contrast,  control  mAb anti-HLA  (W632), anti- 
LFA-1 a chain mAb (TSI-22), and anti-pl50, 95 ¢x chain mAb (3.9) 
failed to significantly inhibit paxillin tyrosine phosphorylation. 
Ligation of CR3 Leads to Paxillin 13vrosine 
Phosphorylation in Transfected K562 Cells 
To determine whether CR3 was sufficient for paxillin tyro- 
sine phosphorylation, we made stable transfectants in K562 
with this integrin (KCR3).  K562 express only the integrin 
oe5/3~ endogenously, and in particular express no/32 integrins 
(23).  As a control, we also transfected K562 with comple- 
ment receptor 2  (CD21), a nonintegrin receptor which rec- 
ognizes a ligand, the complement component C3bi, in com- 
mon with  CR3  (8)  (KCR2).  The  KCR3  and  KCR2  each 
expressed high levels of the transfected receptor (Fig.  5). 
Both  KCR3  and  KCR2  adhered  avidly  and  equally  to  a 
complement-coated surface, with 124 KCR3 adhered/HPF, 
143 KCR2 adhered/HPF,  and <10 vector-transfected K562 
adhered/HPF.  The KCR3 showed significant spreading and 
extension of cellular processes after adhesion (Fig. 6 A). In 
contrast, the majority of the CR2-K562 remained rounded 
and failed to spread on the complement-coated surface (Fig. 
6 B). PaxiUin tyrosine phosphorylation was assessed as well 
in  the  adherent  transfectants.  In  KCR3,  adhesion  to  a 
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Figure 5.  Expression  of CR3 
and CR2 on transfected K562 
cells.  Transfected K562 cells 
were  incubated  with  either 
control  mAb (MOPC  IgG1), 
anti-~2  mAb  IIM,  or  anti- 
CR2 mAb HB5 and analyzed 
by fluorescent flow cytometry. 
CR3 c~ chain mAb 10B5 (16) 
stained  K562-CR3  equiva- 
lently to the/52 mAb (data not 
shown). 
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CR3- (A) and CR2- (B) transfected K562 cells were allowed to ad- 
here  to  complement-coated  surfaces  for  30  min,  followed  by 
Giemsa staining. Despite avid adhesion of both transfectants to the 
surface, there was a marked morphologic difference in the adherent 
cells.  K562 transfected  with  vector alone  did  not adhere  to the 
C3bi-coated  surface (not shown). 
complement-coated  surface  was  associated  with  tyrosine 
/~hosphoryaltion  of paxillin,  while  there  was  no  paxillin 
phosphorylation in the adherent KCR2 (Fig. 7). Thus, CR3 
ligation is sufficient to induce paxillin tyrosine phosphoryla- 
tion in K562 cells and is associated with cell spreading on 
a  complement-coated surface. 
Figure 7. Paxillin tyrosine phosphorylation  in transfectants. CR2- 
and  CR3-transfected  K562  cells  were  incubated  for 30  min in 
suspension or allowed to adhere to a complement-coated surface, 
followed by  paxillin  immunoprecipitation  and  phosphotyrosine 
immunoblotting. Tyrosine phosphorylation of paxillin was not de- 
tected in either transfectant in suspension. Tymsine phosphoryla- 
tion of paxillin was apparent in the CR3 but not the CR2 transfec- 
tant  in  response  to  adhesion  to  a  complement-coated  surface. 
Equivalent paxillin loading in each lane was confirmed by reblot- 
ring with anti-paxiUin mAb (data not shown). Mr markers arc as in 
Fig.  1. 
duced tyrosine phosphorylation of paxillin in KCR3 (Fig. 8). 
C3bi-bead binding in combination with phorbol ester treat- 
ment led to a further increase in paxiUin phosphorylation in 
KCR3.  In contrast KCR2  failed to phosphorylate paxiUin 
even with the combination of ligand and phorbol ester treat- 
ment. Thus, there is a CR3-dependent mechanism for paxil- 
lin tyrosine phosphorylation in both adherent and a nonad- 
herent  K562.  In  contrast  to  PMN,  which  required  only 
phorbol ester treatment to phosphorylate paxillin, the K562 
transfectants required the  addition  of a  CR3  ligand to in- 
duced paxillin phosphorylation. 
Phorbol Esters Are Not SuJficient to Induce PaxiUin 
Phosphorylation in Nonadherent K562 
Since paxillin was phospborylated after phorbol ester treat- 
ment of nonadherent PMN,  we examined whether phorbol 
esters could  cause paxillin phosphorylation in  transfected 
K562 cells in suspension (Fig. 8). KCR3 in suspension either 
with or without phorbol ester treatment showed no paxillin 
tyrosine phosphorylation.  Next,  we tested whether  ligand 
binding by nonadherent cells could stimulate paxillin phos- 
phorylation. Both KCR2 and KCR3 were constitutively ac- 
tive for binding of 3 btm diameter beads coated with C3bi 
(AI: KCR2  =  1369  +  185,  KCR3  =  950  +  155, mean + 
SEM). Addition of this CR3 ligand to cells in suspension in- 
Adhesion Augments the Ability of C3bi to Induce 
Paxillin Phosphorylation in PMN 
Since  a  CR3  ligand  induced  paxillin  phosphorylation  in 
nonadherent KCR3, we tested whether this also was true in 
PMN.  Unlike  KCR3,  which  are  constitutively  active  for 
ligand binding, resting PMN express CR3 which is not in an 
optimal conformation for C3bi binding (28, 32). Cell activa- 
tion by either phorbol esters or fMLP induces a higher CR3 
affinity for C3bi-coated targets and  causes membrane ex- 
pression of an internal pool of CR3.  Since these activation 
stimuli alone induce paxillin phosphorylation in PMN, we 
used  Mn  2+ to  test the  effect of C3bi binding  by PMN on 
paxillin tyrosine phosphorylation.  Addition of Mn  2+ to the 
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binding C3bi-beads. CR3- or CR2-transfected K562 cells were in- 
cubated  in suspension  5:  PDBu  (30 ng/ml) and  +  C3bi-coated 
beads.  Paxillin  immunoprecipitates  were  phosphotyrosine  im- 
munoblotted. The CR3-transfected cells phosphorylated paxillin in 
response to C3bi-bead binding. This paxillin phosphorylation was 
further enhanced  by the  combination  of C3bi-bead  binding  and 
phorbol ester treatment  of the CR3-transfected  cells.  The CR2- 
transfected cells failed to phosphorylate  paxillin even in response 
to the combination of ligand binding and phorbol esters. Mr mark- 
ers are as in Fig.  I. 
Figure 9. Paxillin tyrosine phosphorylation in unactivated PMN in 
response to C3bi ligand. PMN were incubated for 25 min in sus- 
pension with C3bi-opsonized particles (AI =  1294), or adherent 
to a complement-coated  surface, with or without 250 pM Mn  2+. 
Control cells were adherent to an albumin-coated surface. Paxillin 
immunoprecipitates  and immunoblots were prepared as in Fig.  1. 
Cells in suspension showed minimal paxillin tyrosine phosphoryla- 
tion.  Cells  adherent  to the complement-coatr,,d surfaces  demon- 
strated greater paxillin phosphorylation  than cells in suspension. 
Mn  2+ enhanced the paxillin phosphorylation  slightly. 
buffer has been described to augment ligand binding by other 
integrin  molecules  by  inducing  a  conformational  change 
(12).  Similarly,  Mn  2+  markedly  augmented  C3bi-particle 
binding  by  PMN  without  enhancing  receptor  expression 
(C3bi-particle attachment:  Baseline AI  =  180  +  11; with 
Mn  2+  =  1335  5:  162, mean 5:  SEM).  PMN in suspension 
were incubated with C3bi-coated targets, with or without ad- 
dition of Mn  2+ to the buffer. Binding of C3bi by nonadher- 
ent  PMN  induced  minimal paxillin tyrosine phosphoryla- 
tion,  whether or not Mn  2+ was present in the buffer (Fig. 
9). In contrast, adhesion of PMN to a C3bi-coated surface 
resulted  in  detectable  paxillin  tyrosine  phosphorylation, 
which  was  enhanced  by  the  addition  of Mn  2+.  However, 
tyrosine phosphorylation  of paxillin  in  these experiments 
was much less than after phorbol ester activation of PMN, 
suggesting that there are additional activation steps involved 
in efficient paxillin tyrosine phosphorylation beyond ligand 
binding to CR3. 
Discussion 
This study demonstrates a  critical role for the/~  integrin 
CR3 for tyrosine phosphorylation of the cytoskeletal protein 
paxillin in both nonadherent and adherent PMN. Studies in 
LAD PMN, and normal PMN treated with various mAb, all 
demonstrate a requirement for/~2 integrins,  specifically for 
CR3.  Studies  in  transfected  cells  show  that  CR3  ligation 
leads  to  paxillin phosphorylation,  while  equally  avid en- 
gagement  of CR2  with  the  same ligand  does  not.  These 
results  demonstrate that  fluid phase activators  of paxillin 
phosphorylation, such as phorbol esters, fMLP, and TNF-t~ 
all work through a  mechanism which requires the plasma 
membrane integrin, rather than through activation of an ex- 
clusively intracellular signal transduction pathway. 
These data in PMN and the transfected K562 cells lead us 
to the hypothesis that maximal paxillin tyrosine phosphory- 
lation in PMN is a two step process requiring ligand binding 
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provided by phorbol esters, fMLP, TNF-a, or adhesion to a 
C3bi-coated  surface.  This  hypothesis  would  explain  the 
complete  absence  of paxillin  tyrosine phosphorylation  in 
l~2-deficient PMN.  Interestingly,  for PMN  in  suspension, 
only the addition of the activating stimulus is required  for 
paxillin tyrosine phosphorylation, while KCR3 require addi- 
tion of an exogenous CR3 ligand as well. This suggests that 
PMN may contain an endogenous CR3 ligand.  Since PMN 
aggregate in response to phorbol esters and fMLP, it is likely 
that CR3 recognizes another plasma membrane protein on 
PMN which may be serving as the ligand. However, TNF-ot 
induces paxillin phosphorylation and does not cause PMN 
aggregation  (2).  Therefore  it  is  possible  that  transient 
cell-cell or cell-substrate interactions  may be sufficient to 
provide CR3 ligation,  or that activated CR3 may recognize 
a ligand on the same cell. 
For both PMN and KCR3, the activating stimulus can be 
supplied by adhesion to a ligand-coated surface. Thus, adhe- 
sion provides additional signals to the cell beyond integrin 
ligation.  The  fact that  phorbol  esters mimic  this  role  for 
adhesion in both PMN and KCR3 suggests the possibility 
that adhesion may activate a necessary serine/threonlne pro- 
tein kinase which is not activated by integrin ligation.  This 
conclusion is in accord with the discoveries that pp125 F^K 
phosphorylation in platelets also requires a stimulus beyond 
integrin  ligation  (22)  and  that  focal contact  formation  in 
fibroblasts requires protein kinase C activation in addition to 
integrin ligation (31).  This two signal model for activation 
of paxillin phosphorylation with CR3 ligation also is consis- 
tent with the observation that adhesion of unactivated PMN 
to  extracellular  matrix  proteins  is  necessary but not  suf- 
ficient for tyrosine phosphorylation of several unidentified 
proteins (14). In blood cells such as platelets and PMN, the 
additional  step of activating the integrin  receptor from its 
nonavid state to one which will bind ligand also is required. 
Presumably this is an additional protection in vivo against 
the consequences of intravascular PMN or platelet aggrega- 
tion and activation. 
Adhesion of PMN to an immune complex-coated surface 
stimulates paxillin tyrosine phosphorylation, while particu- 
late immune complexes presented to cells in suspension do 
not.  Like  the  other  PMN  activators,  the  immune  com- 
plex-coated surface can only lead to paxillin tyrosine phos- 
phorylation when the PMN express t2 integrins.  Tyrosine 
phosphorylation  of several  other  proteins  in  response  to 
adhesion to immune complexes is unaffected by the absence 
of these integrins.  This observation suggests the hypothesis 
that paxillin tyrosine phosphorylation may be required for 
some functions which occur after PMN Fc'tR ligation which 
have been shown to require B2 integrin  expression.  These 
functions  include  IgG-stimulated  LTB4 production,  sus- 
tained spreading on immune complexes, and maximal IgG- 
mediated phagocytosis after PMN activation with phorbol 
esters, fMLP, TNF-a, and extracellular matrix proteins (17, 
20). The kinetics of paxiUin phosphorylation parallel these 
functions  of  activated  PMN.  In  contrast,  thioglycolate- 
elicited murine macrophages apparently stimulate tyrosine 
phosphorylation of paxillin directly through ligation of the 
transmembrane  form of Fc~RIII,  a  receptor which  PMN 
lack (18). This alternative pathway to tyrosine phosphoryla- 
tion  of paxillin  could  explain  the  independence  from  /32 
integrins of IgG-mediated phagocytosis in these cells. 
Whether  the  tyrosine  phosphorylation  of  paxillin  is 
directly related to function in PMN and other cells is un- 
known. There is a strong correlation between cell spreading 
with paxiUin tyrosine phosphorylation in several cell types 
(7, 26). This is well illustrated by comparison of KCR2 and 
KCR3  in  this  study,  since  the  two  transfectants  adhere 
equivalently to a C3bi-coated surface, but only in the KCR3 
was paxillin  phosphorylation  and  spreading  observed.  A 
much higher proportion of paxillin (20-30 %) becomes phos- 
phorylated in early embryonic cells and transformed fibro- 
blasts than has been reported for other cytoskeletal proteins 
such as talin and vinculin (1%) (15, 26). Our results indicate 
that in PMN only a small proportion of total paxillin is phos- 
phorylated at any given time.  Since paxillin tyrosine phos- 
phorylation has been associated with the presence of focal 
contacts, it is possible that the lower level of paxillin tyrosine 
phosphorylation in PMN reflects their rapid motility when 
activated. When PMN are activated in the presence of phos- 
phatase inhibitors there is a marked increase in the propor- 
tion of paxillin which remains tyrosine phosphorylated, sug- 
gesting that paxillin tyrosine phosphorylation in PMN may 
be tightly regulated by phosphatase activity. Differences in 
level of paxillin tyrosine phosphorylation in different cells 
may  depend  on the balance between tyrosine kinase  and 
phosphatase activity under the conditions studied. Inhibition 
of fibroblast tyrosine kinase  activity inhibits both paxillin 
phosphorylation  and  focal contact formation  suggesting  a 
functional association (7). In mouse macrophages,  paxillin 
localizes to the site of IgG FcR aggregation and phagocyto- 
sis. In the rnacrophages tyrosine kinase inhibitors block both 
phagocytosis and paxillin phosphorylation (18).  In our ex- 
periments in PMN and K562, the tyrosine kinase inhibitors 
genistein, herbimycin, an erbstatin analogue, and tyrphostin 
failed to inhibit paxillin phosphorylation completely (Gra- 
ham, I. L., and E. Brown, unpublished). Thus, even indirect 
tests of whether the phosphorylation itself is necessary for 
function were not possible. Since paxillin is known to pro- 
vide a binding site for the SH3 domains ofsrc family tyrosine 
kinases, it is also possible that the localization of paxillin to 
sites of organized cytoskeleton could serve a role in signal 
transduction which is independent of its tyrosine phosphory- 
lation (30). 
In summary,  CR3 is required for signal transduction  in- 
volving paxillin phosphorylation after activation of adherent 
and nonadherent PMN. This may imply either that CR3 is 
directly involved in activation of a tyrosine kinase, or alter- 
natively, that CR3 is required for localization of paxillin to 
a site of tyrosine kinase activity. Identification of the tyrosine 
kinase involved in paxillin tyrosine phosphorylation in PMN 
may aid in differentiating these possibilities. It is intriguing 
to speculate that CR3-dependent tyrosine phosphorylation of 
paxiUin may be part of a signal transduction pathway leading 
to the transition of PMN from a functionally inactive to ac- 
tive state. If so, activation of this tyrosine kinase represents 
a key step in the inflammatory process. 
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